Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care
Introduction: The serum digoxin concentration (SDC) should be between 0.8 and 2 ng/ml. The objective is to assess the pharmacokinetic monitoring of SDC performed from primary healthcare (PH) in patients with chronic treatment. Methods: Cross-sectional retrospective study of patients with chronic t...
Saved in:
| Main Authors: | Emma M García-Iranzo, Francisco J Rodríguez-Lucena, Carmen Matoses-Chirivella, Ana García-Monsalve, Ana Cristina Murcia-López, Andrés Navarro-Ruiz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-07-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/10748.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MONITORING OF SERUM DIGOXIN CONCENTRATION AND SAFETY OF THERAPY WITH DIGOXIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. F. Zadvorev, et al.
Published: (2018-05-01) -
OPTIMIZATION OF THE HEART RATE CONTROL IN ATRIAL FIBRILLATION BY MONITORING OF THE DIGOXIN CONCENTRATION IN ELDERLY PATIENTS
by: S. F. Zadvorev, et al.
Published: (2018-07-01) -
Digoxin toxicity with therapeutic serum digoxin concentrations
by: J. Graafsma, et al.
Published: (2025-12-01) -
Stone heart syndrome: A curious case of digoxin toxicity and calcium infusion
by: Guleid Hussein, et al.
Published: (2024-09-01) -
Therapeutic drug monitoring of digoxin in cardiac heart failure outpatients: comparisons of two analytical methods
by: Isabel Cristina Medeiros Barros, et al.
Published: (2014-01-01)